MX2012015149A - Agente biocompatible para dispensar nanoparticulas en un medio acuoso usando polimero de proteina mimetica adhesiva de mejillon. - Google Patents

Agente biocompatible para dispensar nanoparticulas en un medio acuoso usando polimero de proteina mimetica adhesiva de mejillon.

Info

Publication number
MX2012015149A
MX2012015149A MX2012015149A MX2012015149A MX2012015149A MX 2012015149 A MX2012015149 A MX 2012015149A MX 2012015149 A MX2012015149 A MX 2012015149A MX 2012015149 A MX2012015149 A MX 2012015149A MX 2012015149 A MX2012015149 A MX 2012015149A
Authority
MX
Mexico
Prior art keywords
aqueous medium
adhesive protein
mussel adhesive
nanoparticles
mimetic
Prior art date
Application number
MX2012015149A
Other languages
English (en)
Inventor
Taeghwan Hyeon
Kun Na
Daishun Ling
Wooram Park
Original Assignee
Hanwha Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanwha Chemical Corp filed Critical Hanwha Chemical Corp
Publication of MX2012015149A publication Critical patent/MX2012015149A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/024Polyamines containing oxygen in the form of ether bonds in the main chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1857Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1887Agglomerates, clusters, i.e. more than one (super)(para)magnetic microparticle or nanoparticle are aggregated or entrapped in the same maxtrix
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/06Cyclic ethers having no atoms other than carbon and hydrogen outside the ring
    • C08G65/08Saturated oxiranes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02Polyalkylene oxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/91Graft copolymers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/10Definition of the polymer structure
    • C08G2261/12Copolymers
    • C08G2261/128Copolymers graft
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00Polymer mixtures characterised by other features
    • C08L2205/03Polymer mixtures characterised by other features containing three or more polymers in a blend

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

La presente invención se refiere a un agente estabilizante de dispersión de proteína mimética adhesiva de mejillón para dispersar nanopartículas en un medio acuoso, una solución coloidal que incluye nanopartículas dispersadas y estabilizadas por el agente estabilizante de dispersión, y un agente de contraste que incluye la solución coloidal. Más particularmente, el estabilizador de dispersión de proteína mimética adhesiva de mejillón es un -injerto depolietilenimina (polietilenglicol; poliDOPA) -injerto de-PEI (PEG; PDOPA). El injerto de polímero se forma de dos partes. Una es polietilenglicol injertado con una polietilenimina la cual tiene una afinidad y un medio acuoso, y el otro es poliDOPA el cual tiene una afinidad a la superficie de nanoparticulas. Debido a estas características, el estabilizador muestra una dispersión estable de nanopartículas en el medio acuoso.
MX2012015149A 2010-12-29 2011-12-28 Agente biocompatible para dispensar nanoparticulas en un medio acuoso usando polimero de proteina mimetica adhesiva de mejillon. MX2012015149A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100137829A KR101685646B1 (ko) 2010-12-29 2010-12-29 홍합 접착단백질 모방을 통한 나노입자를 수계 매질에 분산시키는 생체적합성 분산 안정화제
PCT/KR2011/010230 WO2012091452A2 (en) 2010-12-29 2011-12-28 Biocompatible agent for dispersing nanoparticles into an aqueous medium using mussel adhesive protein-mimetic polymer

Publications (1)

Publication Number Publication Date
MX2012015149A true MX2012015149A (es) 2013-05-06

Family

ID=46383721

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012015149A MX2012015149A (es) 2010-12-29 2011-12-28 Agente biocompatible para dispensar nanoparticulas en un medio acuoso usando polimero de proteina mimetica adhesiva de mejillon.

Country Status (10)

Country Link
US (1) US9169355B2 (es)
EP (1) EP2658896B1 (es)
JP (1) JP5766808B2 (es)
KR (1) KR101685646B1 (es)
CN (1) CN103180364B (es)
BR (1) BR112013010693A2 (es)
CA (1) CA2798371C (es)
MX (1) MX2012015149A (es)
RU (1) RU2541538C1 (es)
WO (1) WO2012091452A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101721570B1 (ko) * 2011-06-22 2017-03-30 한화케미칼 주식회사 산화철 나노입자 기반 림프절 이미징용 mri 조영제 및 이를 이용하여 림프절을 조영하는 방법
CN102911373B (zh) * 2012-08-06 2014-10-15 东华大学 一种hpei包裹的氧化铁磁性纳米颗粒的制备方法
US10780164B2 (en) * 2014-04-03 2020-09-22 The Governing Council Of The University Of Toronto Multifunctional nanoparticle compositions and uses thereof
CN103877956A (zh) * 2014-04-04 2014-06-25 华东理工大学 一种用于分离纯化gst标签融合蛋白的磁性亲和纳米材料及其制备方法和应用
CN104109690B (zh) * 2014-06-19 2017-04-26 中山大学附属第一医院 一种功能化纳米基因导入材料及其制备方法和应用
KR20170106291A (ko) * 2014-09-17 2017-09-20 세이프화이트 인코포레이티드 모발, 피부 또는 손발톱에 제제를 전달하기 위한 방법 및 물질
KR101765335B1 (ko) * 2014-09-26 2017-08-22 서울대학교산학협력단 암 세포 조영용 mri 조영제 조성물
KR101720046B1 (ko) * 2014-09-26 2017-03-29 서울대학교산학협력단 광역학 치료용 자기조립형 약학 조성물
US20180280545A1 (en) * 2014-11-04 2018-10-04 University Of Washington Iron oxide nanoparticles and their synthesis by controlled oxidation
WO2016085411A1 (en) * 2014-11-25 2016-06-02 Nanyang Technological University Method for preparing a magnetic chain structure
CN104722242B (zh) * 2015-01-27 2016-09-28 南方科技大学 星形/多臂嵌段共聚物在制备含有纳米粒子的混合物中的用途
CN104707558B (zh) * 2015-03-17 2017-12-08 武汉理工大学 一种氧化镁粉体材料的制备方法及其制备的氧化镁粉体材料
CN104693810A (zh) * 2015-03-17 2015-06-10 武汉理工大学 一种SiO2/蛋白复合材料的制备方法及其制备的复合材料
CN104987731B (zh) * 2015-07-03 2017-09-26 苏州大学 一维纳米链状Fe3O4/丝蛋白复合物及其制备方法
US11578106B2 (en) 2015-08-07 2023-02-14 TME Therapeutics Co., Ltd. Surfactant adhesive composition
KR20170017499A (ko) * 2015-08-07 2017-02-15 콜로디스 바이오사이언스, 인코포레이티드 계면활성 접착제
KR102283811B1 (ko) * 2016-09-28 2021-07-30 코오롱인더스트리 주식회사 퀴논 경화형 조성물 및 이를 포함하는 접착제 조성물
KR20190126405A (ko) * 2017-03-16 2019-11-11 난양 테크놀러지컬 유니버시티 항균 중합체 및 항균 하이드로겔
US20220125752A1 (en) * 2019-02-12 2022-04-28 University Of Tsukuba Levodopa derivative and use thereof
CN110054696B (zh) * 2019-03-04 2023-08-18 江苏大学 一种贻贝仿生多肽复合磁珠及其制备方法与应用
KR20210016219A (ko) 2019-08-02 2021-02-15 삼성디스플레이 주식회사 발광 소자, 이를 포함하는 표시 장치 및 표시 장치 제조 방법
CN112310403B (zh) * 2021-01-04 2021-04-06 清陶(昆山)能源发展有限公司 一种锂离子电池硅基负极及其制备方法、应用
CN117019595A (zh) * 2023-10-10 2023-11-10 江苏恒美幕墙材料有限公司 一种三维复合铝板的表面耐腐蚀工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284267B1 (en) * 1996-08-14 2001-09-04 Nutrimed Biotech Amphiphilic materials and liposome formulations thereof
US20030059465A1 (en) * 1998-05-11 2003-03-27 Unger Evan C. Stabilized nanoparticle formulations of camptotheca derivatives
DE19933024C2 (de) * 1999-07-15 2003-03-13 Medinnova Ges Med Innovationen Kationische Blockcopolymere
KR100566911B1 (ko) * 2001-06-25 2006-04-03 주식회사 삼양사 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
US7858679B2 (en) 2001-07-20 2010-12-28 Northwestern University Polymeric compositions and related methods of use
KR100669161B1 (ko) * 2002-11-23 2007-01-15 (주)아모레퍼시픽 양친성 공중합체로 제조되는 생분해성 고분자 베지클
US20060083781A1 (en) * 2004-10-14 2006-04-20 Shastri V P Functionalized solid lipid nanoparticles and methods of making and using same
JP2007276299A (ja) 2006-04-07 2007-10-25 Fujifilm Corp インク受容層用塗布液及びその製造方法並びにインクジェット記録媒体及びその製造方法
US7622533B2 (en) * 2006-08-04 2009-11-24 Nerites Corporation Biomimetic compounds and synthetic methods therefor
JP2008069092A (ja) * 2006-09-13 2008-03-27 Fujifilm Corp 配位結合を利用した水分散性磁性粒子
US8088437B2 (en) * 2007-05-16 2012-01-03 Dic Corporation Method for production of silver-containing nano-structure, and silver-containing nano-structure
US20080312174A1 (en) * 2007-06-05 2008-12-18 Nitto Denko Corporation Water soluble crosslinked polymers
US20090004243A1 (en) * 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
US20090280063A1 (en) * 2008-05-09 2009-11-12 General Electric Company Novel pei-peg graft copolymer coating of iron oxide nanoparticles for inflammation imaging
KR101721570B1 (ko) 2011-06-22 2017-03-30 한화케미칼 주식회사 산화철 나노입자 기반 림프절 이미징용 mri 조영제 및 이를 이용하여 림프절을 조영하는 방법

Also Published As

Publication number Publication date
US20130272965A1 (en) 2013-10-17
US9169355B2 (en) 2015-10-27
CN103180364B (zh) 2015-01-07
RU2013104987A (ru) 2015-02-10
KR20120075917A (ko) 2012-07-09
CA2798371C (en) 2016-05-17
CN103180364A (zh) 2013-06-26
EP2658896A4 (en) 2014-09-03
RU2541538C1 (ru) 2015-02-20
JP5766808B2 (ja) 2015-08-19
WO2012091452A3 (en) 2012-10-18
EP2658896B1 (en) 2019-02-20
KR101685646B1 (ko) 2016-12-13
JP2013543014A (ja) 2013-11-28
BR112013010693A2 (pt) 2016-08-09
CA2798371A1 (en) 2012-07-05
EP2658896A2 (en) 2013-11-06
WO2012091452A2 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
MX2012015149A (es) Agente biocompatible para dispensar nanoparticulas en un medio acuoso usando polimero de proteina mimetica adhesiva de mejillon.
TW200711994A (en) Solvent containing carbon nanotube aqueous dispersions
AU2010279931B2 (en) Composition and process for production thereof
WO2012018451A3 (en) Method to disperse nanoparticles into elastomer and articles produced therefrom
TW200745222A (en) Aqueous dispersions for use as toners
PH12015500216A1 (en) Natural rubber containing nanocarbon
MX2020007227A (es) Nanoparticulas farmaceuticas que muestran la mejora del transporte de la mucosa.
EP4218718A3 (en) Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
WO2008084854A1 (ja) セルロース微粒子並びにその分散液及び分散体
WO2008048295A3 (en) Stable dispersions of polymer-coated graphitic nanoplatelets
MX2011012196A (es) Composiciones y metodos para el suministro de farmaco.
GB2452461A (en) Aqueous compositions containing a hydrophobic material
EP1916671A3 (en) Silver-containing nanoparticles with replacement stabilizer
EP2559724A4 (en) NONAQUEOUS DISPERSION OF RESIN PARTICLES
WO2013013030A3 (en) Nanocomposite polymer hydrogel with aligned nanoparticles
MX2010004840A (es) Metodo para construir viscosidad y viscoelasticidad en soluciones surfactantes al adicionar nanoparticulas y composiciones de las mismas.
MX362842B (es) Superficies superhidrofobas de base acuosa no fluorada.
BR112015008333A2 (pt) dispersões de pigmento e tintas de impressão
AU2020390759A8 (en) Water-redispersible graphene powder
MX2012008649A (es) Uso de polietilenimidas como aditivo en suspensiones acuosas de materiales que contienen carbonato calcico.
WO2014183038A3 (en) Nanoparticulates and a linear polymer delivery system
UA105403C2 (ru) Эластический неоргано-органический гибридный пенопласт
MX2011007631A (es) Dispersion polimerica acuosa.
WO2012150383A3 (en) Method for surface modification of a body
WO2016192149A8 (zh) 一类双烷氧酰胺烷基阳离子肽脂质及其合成方法和应用